<DOC>
	<DOCNO>NCT00615030</DOCNO>
	<brief_summary>This study conduct provide detailed information efficacy indacaterol ( term spirometry assessment forced expiratory volume 1 second [ FEV1 ] ) full 24-h time period</brief_summary>
	<brief_title>Study Indacaterol Dosed Evening Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criterion : Male female adult age ≥ 40 year , sign Informed Consent Form prior initiation studyrelated procedure Cooperative outpatient diagnosis chronic obstructive pulmonary disease ( COPD ) ( moderate severe classify Global initiative chronic obstructive lung disease ( GOLD ) Guidelines , 2006 ) : Smoking history least 20 pack year Postbronchodilator FEV1 &lt; 80 % ≥30 % predict normal value Postbronchodilator FEV1/forced vital capacity ( FVC ) &lt; 70 % Exclusion criterion : Pregnant lactating female Patients hospitalize COPD exacerbation 6 week prior Visit 1 runin period Patients require long term oxygen therapy ( &gt; 15 h day ) Patient respiratory tract infection 6 week prior V2 ( criterion ) Patients concomitant pulmonary disease , pulmonary tuberculosis , clinically significant bronchiectasis Patients history asthma ( criterion ) Patients Type I uncontrolled type II diabetes . Patients clinically relevant laboratory abnormality clinically significant abnormality Any patient active cancer history cancer le 5 year disease free survival time Patient history long QT syndrome whose QTc interval prolong Patients hypersensitivity study drug drug similar chemical structure Patients treatment investigational drug ( criterion ) Patients live attenuate vaccination within 30 day prior Visit 2 , runin period Patients know history non compliance medication Patients unable satisfactorily use dry powder inhaler device perform spirometry measurements Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>COPD , bronchodilator , long act beta agonist , LABA</keyword>
</DOC>